Chemical compound, the preparation thereof and its use in pharmaceutical compositions

US5686496A · kind A · utility

Assignee

• Boehringer Ingelheim GmbH · DE

Inventors

• Ralf Anderskewitz · Laupheim, DE
• Kurt Schromm · Ingelheim am Rhein, DE
• Ernst-Otto Renth · Ingelheim am Rhein, DE
• Franz Birke · Ingelheim am Rhein, DE
• Armin Fugner · Gau-Algesheim, DE
• Hubert Heuer · Frankfurt am Main, DE
• Christopher Meade · Bingen, DE

Key dates

• Filing date: Mar 28, 1997
• Grant date: Nov 11, 1997
• Expiry date: Mar 28, 2017

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The new compound of formula ##STR1## may be prepared by conventional methods and used therapeutically as an LTB.sub.4 -receptor antagonist.